Arguably, the World's First Real-time Pathogen Detection Device
In a notable advancement for the fast-moving consumer goods (FMCG) industry, Spore.Bio, a deeptech startup, has recently raised €8 million in a pre-seed funding round. This funding was led by LocalGlobe and will fuel the development and deployment of a groundbreaking technology in the realm of pathogen detection.
Spore.Bio has developed the world's first real-time pathogen detection device, designed for direct use on the factory floor. This technology leverages advanced machine learning models to identify bacteria concentrations in various products, including food, beverages, pharmaceuticals, and cosmetics. With this system, quality managers can be alerted to potential risks much faster than with traditional methods.
Traditionally, quality sampling in factories would take anywhere from five to twenty days, requiring off-site testing in external labs. This process was not only time-consuming but also financially demanding. Spore.Bio’s technology significantly cuts down this time, providing almost real-time insights with unparalleled levels of traceability and transparency. This advancement is not just a step forward in technology but also a crucial development in addressing public health risks, reducing cross-contamination, and minimizing costs.
Founded in 2023 by CEO Amine Raji, CTO Maxime Mistretta, PhD. , and COO Mohamed Tazi, Spore.Bio boasts a team of experts from various fields, including microbiology, machine learning, optics, photonics, and chemometrics.
This team has been instrumental in developing the first functional version of their technology in less than eight months and has already begun signing commercial contracts. Their effort has culminated in a waitlist for their first prototypes, which is already oversubscribed, signaling strong market interest.
